[go: up one dir, main page]

ZA909648B - Process for the preparation of derivatives of 1-phenyl-imidazoline-2,5-dione - Google Patents

Process for the preparation of derivatives of 1-phenyl-imidazoline-2,5-dione

Info

Publication number
ZA909648B
ZA909648B ZA909648A ZA909648A ZA909648B ZA 909648 B ZA909648 B ZA 909648B ZA 909648 A ZA909648 A ZA 909648A ZA 909648 A ZA909648 A ZA 909648A ZA 909648 B ZA909648 B ZA 909648B
Authority
ZA
South Africa
Prior art keywords
phenyl
preparation
formula
image
imidazoline
Prior art date
Application number
ZA909648A
Other languages
English (en)
Inventor
Patrick Seuron
Seuron Patrick
Daniel Varraillon
Varraillon Daniel
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ZA909648B publication Critical patent/ZA909648B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/74Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Reinforced Plastic Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
ZA909648A 1989-12-22 1990-11-30 Process for the preparation of derivatives of 1-phenyl-imidazoline-2,5-dione ZA909648B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8917046A FR2656302B1 (fr) 1989-12-22 1989-12-22 Nouveau procede de preparation de l'anandron et derives de l'anandron.

Publications (1)

Publication Number Publication Date
ZA909648B true ZA909648B (en) 1992-02-26

Family

ID=9388859

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA909648A ZA909648B (en) 1989-12-22 1990-11-30 Process for the preparation of derivatives of 1-phenyl-imidazoline-2,5-dione

Country Status (24)

Country Link
US (1) US5166358A (xx)
EP (1) EP0436426B1 (xx)
JP (1) JP2836041B2 (xx)
KR (1) KR0173307B1 (xx)
CN (1) CN1048011C (xx)
AT (1) ATE107289T1 (xx)
AU (1) AU628699B2 (xx)
CA (1) CA2032988C (xx)
CZ (1) CZ281655B6 (xx)
DE (1) DE69009964T2 (xx)
DK (1) DK0436426T3 (xx)
ES (1) ES2055382T3 (xx)
FI (1) FI103203B1 (xx)
FR (1) FR2656302B1 (xx)
HU (1) HU207301B (xx)
IE (1) IE65510B1 (xx)
IL (1) IL96696A (xx)
NZ (1) NZ236621A (xx)
PL (1) PL164694B1 (xx)
PT (1) PT96313B (xx)
RU (1) RU1836356C (xx)
SK (1) SK278447B6 (xx)
UA (1) UA27220C2 (xx)
ZA (1) ZA909648B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693461B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
US5411981A (en) * 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2694290B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
US5656651A (en) * 1995-06-16 1997-08-12 Biophysica Inc. Androgenic directed compositions
FR2741346B1 (fr) * 1995-11-16 1997-12-19 Roussel Uclaf Nouveau procede de preparation de derives phenylimidazolidine
FR2741342B1 (fr) * 1995-11-22 1998-02-06 Roussel Uclaf Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques
JPH1072446A (ja) * 1996-06-24 1998-03-17 Sumitomo Chem Co Ltd 1−置換−ヒダントイン類の製造法
US7001911B2 (en) 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
IL152719A0 (en) * 2000-06-28 2003-06-24 Bristol Myers Squibb Co Selective androgen receptor modulators and methods for their identification
EP1854798A3 (en) 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
PL206962B1 (pl) 2001-12-19 2010-10-29 Bristol Myers Squibb Co Związek heterocykliczny o budowie skondensowanej
JP2007514442A (ja) * 2003-12-19 2007-06-07 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 前立腺癌治療を評価するための方法および物質
AU2005232526B2 (en) * 2004-02-24 2011-06-23 The Regents Of The University Of California Methods and materials for assessing prostate cancer therapies and compounds
US7709517B2 (en) * 2005-05-13 2010-05-04 The Regents Of The University Of California Diarylhydantoin compounds
LT3100727T (lt) 2006-03-27 2018-12-10 The Regents Of The University Of California Androgeno receptoriaus moduliatorius, skirtas prostatos vėžio ir su androgeno receptoriumi susijusių ligų gydymui
CN101460467B (zh) * 2006-03-29 2012-09-19 加利福尼亚大学董事会 二芳基硫代乙内酰脲化合物
EP2620432A3 (en) 2007-10-26 2013-12-18 The Regents Of the University of California Diarylhydantoin compounds
KR101819199B1 (ko) 2010-02-16 2018-01-16 아라곤 파마슈티컬스, 인코포레이티드 안드로겐 수용체 조절제 및 이의 용도
MY180834A (en) 2012-09-26 2020-12-10 Aragon Pharmaceuticals Inc Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
JOP20200097A1 (ar) 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
JP7201694B2 (ja) 2017-10-16 2023-01-10 アラゴン ファーマシューティカルズ,インコーポレイテッド 非転移性去勢抵抗性前立腺癌の治療のための抗アンドロゲン剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH166004A (de) * 1934-06-06 1933-12-15 Chem Fab Vormals Sandoz Verfahren zur Darstellung eines Derivates des 5,5-Phenyläthylhydantoins.
US2490813A (en) * 1944-11-29 1949-12-13 Standard Oil Co Continuous process for making aryl amines
US2759002A (en) * 1954-03-24 1956-08-14 Abbott Lab 3-benzyl hydantoin and process
US3134663A (en) * 1957-07-23 1964-05-26 Geigy Chem Corp Herbicidal composition and method employing hydantoins
US3914311A (en) * 1973-06-15 1975-10-21 Du Pont Preparation of aromatic secondary and tertiary amines using a nickel complex catalyst
DE2414613A1 (de) * 1974-03-26 1975-10-16 Bayer Ag 1-aryl-5-alkyliden-2,4-dioxo-imidazolidine
FR2329276A1 (fr) * 1975-10-29 1977-05-27 Roussel Uclaf Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant
CA1138334A (en) * 1977-10-28 1982-12-28 Karl Bernauer Pharmaceutical preparations containing certain urea derivatives
GB1598166A (en) * 1978-05-23 1981-09-16 Lilly Industries Ltd 3,5-disubstituted hydantoin derivatives
US4764625A (en) * 1980-12-12 1988-08-16 Xerox Corporation Process for preparing arylamines
DE3382406D1 (de) * 1982-04-08 1991-10-17 Shell Int Research Neue hydantoine, ihre herstellung und verwendung.

Also Published As

Publication number Publication date
IE65510B1 (en) 1995-11-01
CN1048011C (zh) 2000-01-05
AU6826590A (en) 1991-06-27
RU1836356C (ru) 1993-08-23
US5166358A (en) 1992-11-24
IE904142A1 (en) 1991-07-03
IL96696A (en) 1995-08-31
KR910011799A (ko) 1991-08-07
AU628699B2 (en) 1992-09-17
SK656790A3 (en) 1997-06-04
KR0173307B1 (ko) 1999-02-01
PL288365A1 (en) 1991-09-09
HU207301B (en) 1993-03-29
JPH04103573A (ja) 1992-04-06
PT96313B (pt) 1998-06-30
DE69009964D1 (de) 1994-07-21
FI906366L (fi) 1991-06-23
EP0436426B1 (fr) 1994-06-15
CN1052666A (zh) 1991-07-03
DK0436426T3 (da) 1994-07-04
EP0436426A1 (fr) 1991-07-10
CA2032988C (fr) 2003-04-29
ATE107289T1 (de) 1994-07-15
CZ656790A3 (en) 1996-08-14
JP2836041B2 (ja) 1998-12-14
HU908416D0 (en) 1991-07-29
CZ281655B6 (cs) 1996-12-11
FI103203B (fi) 1999-05-14
FI103203B1 (fi) 1999-05-14
ES2055382T3 (es) 1994-08-16
FR2656302A1 (fr) 1991-06-28
NZ236621A (en) 1992-04-28
CA2032988A1 (fr) 1991-06-23
SK278447B6 (en) 1997-06-04
UA27220C2 (uk) 2000-08-15
PT96313A (pt) 1991-09-30
PL164694B1 (pl) 1994-09-30
IL96696A0 (en) 1991-09-16
DE69009964T2 (de) 1994-10-13
FR2656302B1 (fr) 1992-05-07
FI906366A0 (fi) 1990-12-21

Similar Documents

Publication Publication Date Title
IL96696A0 (en) Process for the preparation of derivatives of 1-phenyl-imidazoline-2,5-dione
AU534361B2 (en) Processes
IL103374A0 (en) Process for the preparation of substituted n-(aryl)-1,2,4-triazolopyrimidine-2-sulfonamides
IL67812A (en) Indanylbenzamide derivatives,process for the preparation thereof and fungicidal compositions comprising the same
GR852037B (xx)
FR2665446B1 (fr) Procede et catalyseur comprenant un compose de lanthanide comme additif promoteur pour la synthese directe du dimethyldichlorosilane.
DE3560027D1 (en) Process for the preparation of o,o'-dithiobenzamides
GR3005533T3 (xx)
ATE52082T1 (de) Chinolinderivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
DE3168178D1 (en) 2-(n-aryl-n-1,2,3-thiadiazolyl-carbonyl)-aminobutyrolactones, their preparation, fungicides containing them and their use as fungicides
ATE53839T1 (de) 2,3-dihydro-3-phenyl-benzofuran-2-onacetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
GR3018736T3 (en) 20,21-Dinoreburnamine derivatives, substituted in position 15, process for their preparation and novel intermediates so obtained, their use as medicines and compositions containing them
ES2124102T3 (es) Procedimiento de sustitucion de ciclopentadieno.
ES2013316A6 (es) Un proceso para preparar un derivado de guanidinotiazol
ES483300A1 (es) Un procedimiento para la preparacion de derivados de benzo- diacepina